Table 5.

Factors associated with developing HCC at both baseline and end of treatment on multivariate analysis

Factors	Hazard Ratio	95%CI		p
Baseline-serum zinc <60 µg/dl	6.283	1.655	23.847	0.007
EOT-serum zinc <63 µg/dl	6.011	2.093	17.265	<0.001
Baseline-AFP ≥6.0 ng/dl	8.163	2.188	35.852	0.002
EOT-M2BPGi ≥2.5	12.194	4.184	58.325	<0.001

AFP, α-fetoprotein; CI, confidence interval; HCC, hepatocellular carcinoma; M2BPGi, Mac-2 binding protein glycosylation isomer.